AI-generated summary
The authors studied patients with seasonal affective disorder who responded only partly or not at all to bright light therapy, adding open-label L-tryptophan for two weeks. In the 14 patients who completed treatment, depression scores fell significantly, and 9 showed very good clinical responses. The authors note the study was open-label and that placebo-controlled trials are needed to show efficacy.
- Participants
- 16
- Who or what was studied
- Drug-free adults with seasonal affective disorder (DSM-IV criteria) who had partial or no response to light therapy
- Limits stated in the abstract
- The study was open-label with no placebo control and a small sample, with 14 of 16 patients completing treatment.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Depression, Placebo-controlled, Open-label study, Lux. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.